GHRH activates its own receptor (GHRH-R) on the same somatotroph cells, primarily through cAMP-protein kinase A signaling
Additionally, while weight loss occurs in most patients treated for diabetes, the medication should only be prescribed for weight management or OSA under the specific Zepbound indication when appropriate criteria are met
Some patients report fatigue, dizziness, or headache, particularly during the initial weeks of treatment
It pulses growth hormone from the anterior pituitary without the cortisol or prolactin spikes associated with older GHRPs
Dermatological monitoring is important with either peptide: MT-2 carries higher risk of mole darkening and new nevi formation due to more potent melanocyte stimulation MT-1's eumelanin shift may actually be somewhat protective, but vigilance is still warranted Anyone with a history of melanoma or atypical moles should exercise extreme caution with either peptide Dosing Protocols Compared Melanotan-1 Protocol UV exposure: 1530 minutes daily during loading, regular exposure during maintenance